News
STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
Novo has agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma
More in Health
- Tell us: have you had the shingles vaccine in the hope of reducing your dementia risk? The Guardian — Society
- Scrapping pensions triple lock 'morally wrong', says union boss BBC News — Health
- Tennessee's failed execution ignites a medical ethics debate NPR — Health
- Pennsylvania Measles Outbreak Grows to Nearly 900 Cases The New York Times — Health
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health World Health Organization